COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits

Transfus Clin Biol. 2021 Nov;28(4):424-425. doi: 10.1016/j.tracli.2021.06.001. Epub 2021 Jun 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Coronavirus Infections*
  • Humans
  • Immunization, Passive
  • Risk Assessment
  • SARS-CoV-2